Published in Health and Medicine Week, September 15th, 2003
In a recent study, scientists in the United States "retrospectively compared the effects of two time points of G-CSF (Filgrastim) introduction for PBSC mobilization in 45 children with different malignancies."
"Seventeen patients received the first G-CSF dose on day 2 or 3 following chemotherapy (group 1)," while "twenty-eight patients received a 'flexible' G-CSF injection schedule when the G-GSF was started at the time of the first platelet count rise during post-chemotherapy recovery phase (group 2)," according to I. Dolgopolov and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.